LGND Notícias Forex
Ligand Says Merck Receives FDA Approval For CAPVAXIVE For Adults
Ligand Pharmaceuticals Inc. (LGND) announced Tuesday that its collaborator Merck & Co., Inc. (MRK), known as MSD outside the U.S. and Canada, has received approval from the U.S. Food and Drug Administration (FDA) for CAPVAXIVE, previously known as V116, a 21-valent pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in the adult population.
RTTNews
|
227 dias atrás
Ligand Pharma CEO John Higgins Retires; Todd Davis To Succeed Higgins As CEO
Ligand Pharmaceuticals Inc. (LGND) announced Monday that John Higgins has retired as Chief Executive Officer, effective as of today. Higgins will resign as a director of the company on December 31, 2022.
RTTNews
|
788 dias atrás
